HB0974 amends Maryland’s health insurance preventive-services law to clarify how certain preventive care coverage rules apply to high deductible health plans. The bill allows a carrier to apply the plan deductible to preventive services required under the statute unless the Maryland Insurance Commissioner determines the service falls within the federal safe-harbor rules for preventive care under the Internal Revenue Code. It also updates the state law’s references to federal preventive-services standards, tying enforcement to the most recent recommendations and guidelines from the U.S. Preventive Services Task Force, the Advisory Committee on Immunization Practices, and the Health Resources and Services Administration as of December 31, 2024.
The bill further authorizes the Commissioner to adopt regulations consistent with federal statutes, rules, and guidance in effect on that date, and to update regulations later if doing so expands consumer preventive-service coverage. It also permits regulations requiring no cost-sharing for future preventive-services recommendations issued after December 31, 2024, by the relevant federal agencies. The act takes effect June 1, 2025, and amends Maryland Insurance Article § 15-1A-10.
In practical terms, the bill affects health carriers, insureds, and enrollees in Maryland, especially those enrolled in high deductible health plans. It preserves the general rule that preventive services are covered without copayments, coinsurance, or deductibles, while creating a specific carve-out for high deductible plans and aligning state enforcement with evolving federal preventive-care standards. It also preserves existing authority for network plans to apply cost-sharing to out-of-network preventive services where otherwise allowed by law.
The available context shows no recorded committee transcript or vote history, so there is no documented floor or committee debate to gauge sentiment. Based on the text, the bill appears largely technical and administrative, aimed at conforming Maryland law to federal preventive-care guidance and clarifying commissioner enforcement authority rather than changing the overall policy of preventive coverage. Any contention would likely center on the high deductible health plan deductible carve-out and the extent of the Commissioner’s future regulatory authority, but no specific opposition is reflected in the provided materials.
HB0974 amends Maryland Insurance Article § 15-1A-10 to clarify preventive-services coverage requirements for health benefit plans, especially high deductible health plans. It gives the Maryland Insurance Commissioner explicit authority to enforce the section in line with federal preventive-care recommendations and guidance, and to adopt regulations consistent with federal law or expanding consumer preventive coverage. The bill preserves the general no-cost-sharing rule for covered preventive services while allowing deductibles to apply in certain high deductible plans unless federal safe-harbor rules say otherwise.
No committee transcript or vote record is provided, so there is no direct evidence of debate, support, or opposition. The bill’s language suggests a generally technical, conformity-oriented measure focused on aligning state law with federal preventive-care standards and clarifying enforcement, which typically indicates neutral to favorable legislative sentiment. The absence of recorded controversy in the supplied materials also suggests limited visible opposition in the available record.
The main potential points of contention are the treatment of high deductible health plans and the scope of the Insurance Commissioner’s authority to enforce and update preventive-services rules. Consumer advocates could favor broader no-cost-sharing coverage, while insurers may support the deductible clarification and the tie to federal safe-harbor rules. Another possible issue is the bill’s authorization for future regulations tied to later federal recommendations, which could be seen as either a consumer-protection mechanism or an expansion of administrative discretion. No specific opposing or supporting stakeholders are identified in the provided materials.